Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Daniel Mekonnen, Hylemariam Mihiretie Mengist & Tengchuan Jin. (2022) SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways. Expert Review of Vaccines 21:1, pages 69-81.
Read now
Read now
Srinivasa Reddy Bonam, Jaggaiah Naidu Gorantla, Arun Kumar Thangarasu, Ravi Shankar Lankalapalli & Halmuthur Mahabalarao Sampath Kumar. (2018) Polyhydroxy-N-alkyl-2-pyrrolidinones as a new class of glycolipid analogues with immune modulation potential. Journal of Carbohydrate Chemistry 37:1, pages 30-43.
Read now
Read now
Carl R Alving, Mangala Rao, Nicholas J Steers, Gary R Matyas & Alexander V Mayorov. (2012) Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines. Expert Review of Vaccines 11:6, pages 733-744.
Read now
Read now
Articles from other publishers (45)
Tosha Pandya, Prachi Joshi, Rudree Pathak & Shreeraj Shah. (2023) Nano-vaccination Strategies: Applications and Challenges for Intranasal
Immunization. Current Pharmaceutical Biotechnology 24:8, pages 946-969.
Crossref
Crossref
Amjad Islam Aqib, Khazeena Atta, Afshan Muneer, Muhammad Luqman Sohail, Kashif Rahim & Firasat Hussain. 2023. Application of Natural Products in SARS-CoV-2. Application of Natural Products in SARS-CoV-2
491
507
.
Je-Young Park, Niamh Corduff, Jürgen Frevert, Rungsima Wanitphakdeedecha & Yates Y.Y. Chao. (2022) Immunogenicity Associated with Aesthetic Botulinumtoxin A: A Survey of Asia-Pacific Physicians’ Experiences and Recommendations. Plastic and Reconstructive Surgery - Global Open 10:4, pages e4217.
Crossref
Crossref
Prasanta Kumar Sarkar & Chitrangada Das Mukhopadhyay. (2022) Mechanistic insights from the review and evaluation of ayurvedic herbal medicines for the prevention and management of COVID-19 patients. Journal of Herbal Medicine 32, pages 100554.
Crossref
Crossref
Saeed Mohammadian Haftcheshmeh, Parvin Zamani, Mohammad Mashreghi, Amin Reza Nikpoor, Jalil Tavakkol‐Afshari & Mahmoud Reza Jaafari. (2020)
Immunoliposomes bearing lymphocyte activation gene 3 fusion protein and
P5
peptide: A novel vaccine for breast cancer
. Biotechnology Progress 37:2.
Crossref
Crossref
Youssof Sefidi-Heris, Abolfazl Jahangiri, Ahad Mokhtarzadeh, Mohammad-Ali Shahbazi, Saeed Khalili, Behzad Baradaran, Jafar Mosafer, Amir Baghbanzadeh, Maryam Hejazi, Mahmoud Hashemzaei, Michael R. Hamblin & Hélder A. Santos. (2020) Recent progress in the design of DNA vaccines against tuberculosis. Drug Discovery Today 25:11, pages 1971-1987.
Crossref
Crossref
Parvin Zamani, Jamshid Gholizadeh Navashenaq, Amin Reza Nikpoor, Mahdi Hatamipour, Reza Kazemi Oskuee, Ali Badiee & Mahmoud Reza Jaafari. (2019) MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer. Journal of Controlled Release 303, pages 223-236.
Crossref
Crossref
Parvin Zamani, Amir Abbas Momtazi‐Borojeni, Maryam Ebrahimi Nik, Reza Kazemi Oskuee & Amirhossein Sahebkar. (2018) Nanoliposomes as the adjuvant delivery systems in cancer immunotherapy. Journal of Cellular Physiology 233:7, pages 5189-5199.
Crossref
Crossref
Lea Bayer, Jessica Gümpel, Gerd Hause, Martin Müller & Thomas Grunwald. (2018) Non-human papillomaviruses for gene delivery in vitro and in vivo. PLOS ONE 13:6, pages e0198996.
Crossref
Crossref
Heejung Jung, Dajeong Kim, Yoon Young Kang, Hyejin Kim, Jong Bum Lee & Hyejung Mok. (2018) CpG incorporated DNA microparticles for elevated immune stimulation for antigen presenting cells. RSC Advances 8:12, pages 6608-6615.
Crossref
Crossref
Manolya Saydam, Woei Ping Cheng, Nathan Palmer, Robert Tierney, Robert Francis, Kirsty MacLellan-Gibson, Ambreen Khan & Fatme Mawas. (2017) Nano-sized Soluplus® polymeric micelles enhance the induction of tetanus toxin neutralising antibody response following transcutaneous immunisation with tetanus toxoid. Vaccine 35:18, pages 2489-2495.
Crossref
Crossref
Emilia Bigaeva, Eva van Doorn, Heng Liu & Eelko Hak. (2016) Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability. PLOS ONE 11:5, pages e0154757.
Crossref
Crossref
Signe Tandrup Schmidt, Camilla Foged, Karen Smith Korsholm, Thomas Rades & Dennis Christensen. (2016) Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators. Pharmaceutics 8:1, pages 7.
Crossref
Crossref
Takami Akagi & Mitsuru Akashi. 2016. Nanomaterials in Pharmacology. Nanomaterials in Pharmacology
439
455
.
Liqing Chen, Juan Zhang & Hongxiang Sun. (2015) Immunological adjuvant effect of the peptide fraction from the larvae of Musca domestica. BMC Complementary and Alternative Medicine 15:1.
Crossref
Crossref
A. Galliher-Beckley, L.K. Pappan, Rachel Madera, Y. Burakova, A. Waters, M. Nickles, X. Li, J. Nietfeld, J.R. Schlup, Q. Zhong, S. McVey, S.S. Dritz & J. Shi. (2015) Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines. Vaccine 33:25, pages 2903-2908.
Crossref
Crossref
Motoyasu Onishi, Koji Ozasa, Kouji Kobiyama, Keiichi Ohata, Mitsutaka Kitano, Keiichi Taniguchi, Tomoyuki Homma, Masanori Kobayashi, Akihiko Sato, Yuko Katakai, Yasuhiro Yasutomi, Edward Wijaya, Yoshinobu Igarashi, Noriyuki Nakatsu, Wataru Ise, Takeshi Inoue, Hiroshi Yamada, Alexis Vandenbon, Daron M. Standley, Tomohiro Kurosaki, Cevayir Coban, Taiki Aoshi, Etsushi Kuroda & Ken J. Ishii. (2015) Hydroxypropyl-β-Cyclodextrin Spikes Local Inflammation That Induces Th2 Cell and T Follicular Helper Cell Responses to the Coadministered Antigen. The Journal of Immunology 194:6, pages 2673-2682.
Crossref
Crossref
Arjun Seth, Fiona K. Ritchie, Nani Wibowo, Linda H. L. Lua & Anton P. J. Middelberg. (2015) Non-Carrier Nanoparticles Adjuvant Modular Protein Vaccine in a Particle-Dependent Manner. PLOS ONE 10:3, pages e0117203.
Crossref
Crossref
Jan ter Meulen, Danilo Casimiro, Beth-Ann Coller, Jon Heinrichs & Akhilesh Bhambhani. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
251
287
.
Amapola ManriqueElizabeth AdamsDan H. BarouchPat FastBarney S. GrahamJerome H. KimJames G. KublinMargaret McCluskeyGiuseppe PantaleoHarriet L. RobinsonNina RussellWilliam SnowMargaret I. Johnston. (2014) The Immune Space: A Concept and Template for Rationalizing Vaccine Development. AIDS Research and Human Retroviruses 30:11, pages 1017-1022.
Crossref
Crossref
Hongxiang Sun, Shuwang He & Minghua Shi. (2014) Adjuvant-active fraction from Albizia julibrissin saponins improves immune responses by inducing cytokine and chemokine at the site of injection. International Immunopharmacology 22:2, pages 346-355.
Crossref
Crossref
Rishab K. Gupta & Mark C. Glassy. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
1289
1308
.
Ryuta Uraki, Subash C. Das, Masato Hatta, Maki Kiso, Kiyoko Iwatsuki-Horimoto, Makoto Ozawa, Cevayir Coban, Ken J. Ishii & Yoshihiro Kawaoka. (2014) Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine. Vaccine 32:41, pages 5295-5300.
Crossref
Crossref
Ozan S. Kumru, Sangeeta B. Joshi, Dawn E. Smith, C. Russell Middaugh, Ted Prusik & David B. Volkin. (2014) Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies. Biologicals 42:5, pages 237-259.
Crossref
Crossref
Deborah L. Novicki, Jayanthi J. Wolf, Lisa M. Plitnick & Melanie Hartsough. 2014. The Role of the Study Director in Nonclinical Studies. The Role of the Study Director in Nonclinical Studies
439
463
.
Nani Wibowo, Yap P. Chuan, Arjun Seth, Yoann Cordoba, Linda H.L. Lua & Anton P.J. Middelberg. (2014) Co-administration of non-carrier nanoparticles boosts antigen immune response without requiring protein conjugation. Vaccine 32:29, pages 3664-3669.
Crossref
Crossref
Benoît Levast, Sunita Awate, Lorne Babiuk, George Mutwiri, Volker Gerdts & Sylvia van Drunen Littel-van den Hurk. (2014) Vaccine Potentiation by Combination Adjuvants. Vaccines 2:2, pages 297-322.
Crossref
Crossref
Alexis García & Juan B. De Sanctis. (2014) An overview of adjuvant formulations and delivery systems. APMIS 122:4, pages 257-267.
Crossref
Crossref
Rajesh K. Gupta. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
32
.
Hiraku Sasaki, Hiroki Ishikawa, Ken Kojima, Masahiro Itoh, Tetsuya Matsumoto, Takumi Itoh, Osamu Hosomi & Eiichi Kawamoto. (2013) Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice. Vaccine 31:48, pages 5729-5735.
Crossref
Crossref
Sérgio P. Fernandes da Costa, Dorien Mot, Monika Bokori-Brown, Christos G. Savva, Ajit K. Basak, Filip Van Immerseel & Richard W. Titball. (2013) Protection against avian necrotic enteritis after immunisation with NetB genetic or formaldehyde toxoids. Vaccine 31:37, pages 4003-4008.
Crossref
Crossref
R. Segura-Velázquez, J. Cervantes, E. Acosta, I. Sánchez-Betancourt, N. Villalobos, L.F. Rodarte, M. Restelli, G. Fragoso & E. Sciutto. (2013) Influenza vaccine: Development of a novel intranasal and subcutaneous recombinant adjuvant. Vaccine 31:37, pages 4009-4016.
Crossref
Crossref
Gary R. Matyas, Alexander V. Mayorov, Kenner C. Rice, Arthur E. Jacobson, Kejun Cheng, Malliga R. Iyer, Fuying Li, Zoltan Beck, Kim D. Janda & Carl R. Alving. (2013) Liposomes containing monophosphoryl lipid A: A potent adjuvant system for inducing antibodies to heroin hapten analogs. Vaccine 31:26, pages 2804-2810.
Crossref
Crossref
Subhadip Raychaudhuri. (2013) The Problem of Antigen Affinity Discrimination in B-Cell Immunology. ISRN Biomathematics 2013, pages 1-18.
Crossref
Crossref
Jayanthi J. Wolf. 2013. Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics. Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics
243
255
.
Jayanthi J. Wolf, Lisa M. Plitnick & Danuta J. Herzyk. 2013. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines
323
349
.
Ashwini Kumar Giddam, Mehfuz Zaman, Mariusz Skwarczynski & Istvan Toth. (2012) Liposome-based delivery system for vaccine candidates: constructing an effective formulation. Nanomedicine 7:12, pages 1877-1893.
Crossref
Crossref
Erin M. Jackson & Melissa M. Herbst-Kralovetz. (2012) Intranasal Vaccination with Murabutide Enhances Humoral and Mucosal Immune Responses to a Virus-Like Particle Vaccine. PLoS ONE 7:7, pages e41529.
Crossref
Crossref
Masashi Okamura, Wakako Matsumoto, Fumio Seike, Yuuya Tanaka, Chie Teratani, Maki Tozuka, Takashige Kashimoto, Kazuaki Takehara, Masayuki Nakamura & Yasuhiro Yoshikawa. (2012) Efficacy of Soluble Recombinant FliC Protein from Salmonella enterica Serovar Enteritidis as a Potential Vaccine Candidate Against Homologous Challenge in Chickens. Avian Diseases 56:2, pages 354-358.
Crossref
Crossref
Rachel P. J. Lai, Michael S. Seaman, Paul Tonks, Frank Wegmann, David J. Seilly, Simon D. W. Frost, Celia C. LaBranche, David C. Montefiori, Antu K. Dey, Indresh K. Srivastava, Quentin Sattentau, Susan W. Barnett & Jonathan L. Heeney. (2012) Mixed Adjuvant Formulations Reveal a New Combination That Elicit Antibody Response Comparable to Freund's Adjuvants. PLoS ONE 7:4, pages e35083.
Crossref
Crossref
Antu K. Dey, Brian Burke, Yide Sun, Karin Hartog, Jonathan L. Heeney, David Montefiori, Indresh K. Srivastava & Susan W. Barnett. (2012) Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein. Vaccine 30:17, pages 2749-2759.
Crossref
Crossref
Rimma Libanova, Pablo D. Becker & Carlos A. Guzmán. (2012) Cyclic di-nucleotides: new era for small molecules as adjuvants. Microbial Biotechnology 5:2, pages 168-176.
Crossref
Crossref
Diana Boraschi, Luca Costantino & Paola Italiani. (2012) Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. Nanomedicine 7:1, pages 121-131.
Crossref
Crossref
Fatima K. Ahmed, Brenda E. Clark, Dennis R. Burton & Ralph Pantophlet. (2012) An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site. Vaccine 30:5, pages 922-930.
Crossref
Crossref
Brian Greenwood, David Salisbury & Adrian V. S. Hill. (2011) Vaccines and global health. Philosophical Transactions of the Royal Society B: Biological Sciences 366:1579, pages 2733-2742.
Crossref
Crossref